Earnings Feed
Sign Up
Home/Insiders/EVNIN ANTHONY B
EA
SEC Insider//CIK 0001239241

EVNIN ANTHONY B

CIK 00012392415 companiesNEW YORK, NY
SEC Profile

Transactions

50

Companies

5

Filings

2

CIK

0001239241

Recent Transactions

50 trades
  • Award
    RENOVIS INC

    Nonstatutory Stock Option (Right to Buy)

    2006-01-16+11,111→ 11,111 total
  • Award
    RENOVIS INC

    Nonstatutory Stock Option (Right to Buy)

    2006-01-16+11,111→ 11,111 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+73,751→ 855,371 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+73,751→ 855,371 total
  • Conversion
    ICAGEN INC

    Series F Convertible Preferred Stock

    2005-02-08−150,880→ 0 total
  • Conversion
    ICAGEN INC

    Series F Convertible Preferred Stock

    2005-02-08−217,120→ 0 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+406,546→ 425,851 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+76,875→ 704,855 total
  • Conversion
    ICAGEN INC

    Series H Convertible Preferred Stock

    2005-02-08−76,875→ 0 total
  • Conversion
    ICAGEN INC

    Series D Convertible Preferred Stock

    2005-02-08−406,546→ 0 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+110,625→ 965,996 total
  • Conversion
    ICAGEN INC

    Series G-1 Convertible Preferred Stock

    2005-02-08−73,751→ 0 total
  • Conversion
    ICAGEN INC

    Series G-1 Convertible Preferred Stock

    2005-02-08−51,249→ 0 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+51,249→ 627,980 total
  • Conversion
    ICAGEN INC

    Series D Convertible Preferred Stock

    2005-02-08−538,909→ 0 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+538,909→ 564,500 total
  • Conversion
    ICAGEN INC

    Series H Convertible Preferred Stock

    2005-02-08−110,625→ 0 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+150,880→ 576,731 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+217,120→ 781,620 total
  • Conversion
    ICAGEN INC

    Series G-1 Convertible Preferred Stock

    2005-02-08−51,249→ 0 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+150,880→ 576,731 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+76,875→ 704,855 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+217,120→ 781,620 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+110,625→ 965,996 total
  • Conversion
    ICAGEN INC

    Series G-1 Convertible Preferred Stock

    2005-02-08−73,751→ 0 total
  • Conversion
    ICAGEN INC

    Series H Convertible Preferred Stock

    2005-02-08−110,625→ 0 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+538,909→ 564,500 total
  • Conversion
    ICAGEN INC

    Series H Convertible Preferred Stock

    2005-02-08−76,875→ 0 total
  • Conversion
    ICAGEN INC

    Series F Convertible Preferred Stock

    2005-02-08−217,120→ 0 total
  • Conversion
    ICAGEN INC

    Series F Convertible Preferred Stock

    2005-02-08−150,880→ 0 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+406,546→ 425,851 total
  • Conversion
    ICAGEN INC

    Common Stock

    2005-02-08+51,249→ 627,980 total
  • Conversion
    ICAGEN INC

    Series D Convertible Preferred Stock

    2005-02-08−406,546→ 0 total
  • Conversion
    ICAGEN INC

    Series D Convertible Preferred Stock

    2005-02-08−538,909→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+274,418→ 747,401 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+190,697→ 535,523 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+201,555→ 472,983 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+274,418→ 747,401 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+204,762→ 204,762 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+140,064→ 344,826 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+14,233→ 14,233 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Common Stock

    2004-04-08+271,428→ 271,428 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series C Convertible Preferred Stock

    2004-04-08−393,600→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series C Convertible Preferred Stock

    2004-04-08−393,600→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series B Convertible Preferred Stock

    2004-04-08−614,286→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series C Convertible Preferred Stock

    2004-04-08−40,000→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series C Convertible Preferred Stock

    2004-04-08−566,400→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series B Convertible Preferred Stock

    2004-04-08−814,286→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series D Convertible Preferred Stock

    2004-04-08−572,093→ 0 total
  • Conversion
    MEMORY PHARMACEUTICALS CORP

    Series D Convertible Preferred Stock

    2004-04-08−823,256→ 0 total

Companies

5

Recent Filings

2

Address

C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA, ROOM 5508

NEW YORK, NY, 10112

View on SEC.gov